the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Anwar: Malaysia’s national debt has reached RM1.5 trillion

PUTRAJAYA: The national debt, including liabilities, has hit RM1.5 trillion and needs to be urgently addressed, according to Prime Minister Datuk Seri Anwar Ibrahim.

Anwar, who is also Finance Minister, said the country’s economic position is still not strong and also affected by external developments.

“The economy is still considered soft. It is also due to international developments such as the Russia-Ukraine conflict and the global economy which has yet to recover fully post-Covid-19.

“Based on the International Monetary Fund’s economic forecast, the downtrend continues. The challenge (for the government) is that the national debt has reached almost RM1.2 trillion. If liabilities are included, the figure has hit RM1.5 trillion,” he said during the Budget 2023 dialogue here today.

Hence, he said, the government will not take the “business as usual” approach but will instead adopt another approach in order to strengthen the country’s economy.

“That is why we present the real figures. Debt service charges for 2023 amount to RM45 billion, representing 15 per cent of the national revenue, and this is also the maximum that the country can handle.

“We cannot be under the impression that we are entering 2023 in a comfortable position. If there is a culture of complacency, we will not be able to drive the desired economic growth,” Anwar said. -Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings